CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 217 enrolled
Drug / intervention
Inofolic: myo-inositol and folic aciddietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02385396
NCT02385396Phase 2Completed
CompareCT.gov

Evaluation Concerning the Influence of Myo-inositol Therapy on the Dynamics of Embryo Development in Patients Suffering From PCOS Undergoing ICSI Treatment

Medical University of Lublin·interventional·Posted Mar 11, 2015·Updated Mar 12, 2015

In Brief

A Phase 2 clinical trial evaluating Inofolic: myo-inositol and folic acid for Polycystic Ovary Syndrome and Infertility. Completed, enrolled 217 participants across 1 site.

Detailed Summary

The purpose of this study is to analyse the activity of myo-inositol on pregnancy rate, embryo development dynamics and oestradiol and progesterone concentration in blood serum and Superoxide Dismutase (SOD) and catalase concentration in follicular fluid of patients with Polycystic Ovary Syndrome (PCOS) undergoing Intracytoplasmic Sperm Injection (ICSI).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Ovary Syndrome, Infertility
CountriesPoland
Collaborators--

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 11, 2015
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Posted 11.3 years ago

Interventions

Inofolic: myo-inositol and folic aciddietary

4000 mg of myo-inositol and 0,4 mg of folic acid for 3 months preceding the ICSI procedure